Mechanism of Action and Pharmacokinetics
Glaucine acts directly on the central nervous system. Its primary target is the cough center located in the medulla oblongata. The drug directly blocks the central components of the cough reflex, reducing their excitability.
A crucial pharmacodynamic feature is that it does not activate the opioidergic system. This fundamentally distinguishes it from narcotic antitussives (such as Codeinum or ethylmorphine), which exert their effects by stimulating opioid receptors.
Pharmacokinetic profile:
- Absorption: The drug is well absorbed from the gastrointestinal tract after oral administration.
- Onset of action: The therapeutic effect develops rapidly—within 30 minutes of administration.
- Duration: The effect lasts approximately 8 hours, allowing for a reduced dosing frequency.
Pharmacological Effects and Classification
According to the classification of drugs affecting respiratory function, glaucine is categorized as a centrally acting antitussive.
Its primary effect is antitussive. However, unlike opioid analgesics, glaucine has several clinical advantages:
- No abuse potential: The drug does not cause drug dependence (tolerance and addiction).
- Respiratory safety: It has a much milder effect on the respiratory center, avoiding dangerous respiratory depression (whereas codeine has pronounced sedative effects and suppresses respiration).
In its pharmacological profile, glaucine is closest to the synthetic agent Oxeladinum (oxeladine). For differential diagnosis, it is important to remember that peripherally acting agents also exist (e.g., Prenoxdiazinum); they work differently by reducing receptor sensitivity directly in the airways rather than in the brain.
Indications for Use
The drug is prescribed for the symptomatic treatment of conditions accompanied by a dry, debilitating, non-productive cough. The main goal is to suppress a hyperactive cough reflex that serves no protective function (does not clear mucus) but exhausts the patient.
Medical Student Note: In pharmacology exams, drugs of this class are frequently contrasted with mucolytics and expectorants (such as ambroxol, bromhexine, acetylcysteine). Mucolytics promote mucus clearance, and their action is incompatible with the suppression of the cough reflex.
Side Effects
Although glaucine lacks opioid side effects (such as constipation or respiratory depression), it has its own profile of adverse reactions.
Key side effects frequently featured in exam questions:
- Decreased blood pressure (hypotension): The most specific effect of this plant alkaloid.
- Dizziness: Often secondary to the drop in blood pressure.
- Nausea: Possible as a gastrointestinal reaction.
Formulations and Prescription Writing
In prescription references, Glaucini hydrochloridum is presented as a solid oral dosage form.
- Formulation: Tablets, 0.05 g.
- Route of administration: Oral.
- Single dose: 0.05 g.
Prescription Example:
Rp.: Tab. Glaucini hydrochloridi 0.05 D.t.d. N. 20 S. Take 1 tablet orally 2–3 times a day.